IOL Life Sciences incorporated as a subsidiary of IOL Chemicals and Pharmaceuticals
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
The capacity addition in Suwa is part of Saint-Gobain Life Sciences ongoing investment plan to globally expand production capacity for its products and services used throughout the bioprocessing industry
Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals
ZS and Quartic will collaborate to help drive resilience, increase adoption of Industry 4.0 and improve predictive decision-making across manufacturing
This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India
This is the first major brand refresh of CanSinoBIO since its inception in 2009
Under the terms of the partnership agreement, Comera will develop a differentiated formulation of an Intas product using Comera's innovative proprietary SQore formulation platform
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
Through this partnership, Premas will connect with genomics labs to provide automated NGS solutions
The facility will produce 150 million vaccine doses per year
Subscribe To Our Newsletter & Stay Updated